Immunological tolerance is achieved through the elimination of self antigen-specific T cell clones generated in the thymus and through the active suppression, by regulatory T cells (T reg cells), of autoreactive T cells that have escaped the thymus to the periphery 1 . T reg cells express the signature transcription factor Foxp3 and have a distinct metabolic, proliferation and cytokine profile 2, 3 . These characteristics are inherent to their ability to suppress, which allows them to maintain immunological homeostasis. Loss of T reg cell function leads invariably to autoimmunity in mice 4 and humans 5 .
Immunological tolerance is achieved through the elimination of self antigen-specific T cell clones generated in the thymus and through the active suppression, by regulatory T cells (T reg cells), of autoreactive T cells that have escaped the thymus to the periphery 1 . T reg cells express the signature transcription factor Foxp3 and have a distinct metabolic, proliferation and cytokine profile 2, 3 . These characteristics are inherent to their ability to suppress, which allows them to maintain immunological homeostasis. Loss of T reg cell function leads invariably to autoimmunity in mice 4 and humans 5 .
PP2A is a highly conserved serine-threonine phosphatase that is the assembly product of three distinct subunits-the scaffold A subunit (PP2A A ), the regulatory B subunit (PP2A B ) and the catalytic C subunit (PP2A C )-into a trimolecular complex 6, 7 . The heterodimer of the scaffold A subunit and the catalytic C subunit (PP2A A -PP2A C ) forms the PP2A core enzyme that associates with one of the regulatory B subunits. The PP2A holocomplex regulates key cellular processes, such as cellcycle progression, apoptosis, cellular metabolism and migration 7 . PP2A is involved in the development of cancer 8 , neurodegenerative diseases 9 and systemic lupus erythematosus 10 . In systemic lupus erythematosus, PP2A has been linked to regulation of the production of interleukin 2 (IL-2) and IL-17 by CD4 + T cells and to the control of T cell apoptosis induced by IL-2 deprivation 10, 11 . Furthermore, PP2A has a central role in tolerance to endotoxins that is dependent on the adaptor MyD88 (ref. 12 ), in T cell-mediated anti-tumor responses 13 and in the termination of transcription factor IRF3-dependent signaling via type I interferons after viral infection 14 .
T reg cells depend on several activating signals, including the T cell antigen receptor (TCR), coreceptor CD28 and IL-2 signaling pathways, for their survival and function. Specifically, T reg cells are agonist selected by high-affinity TCR ligands in the thymus 15 , and continuous TCR engagement is required for their maintenance in the periphery 16 . Loss of signaling via CD28 (ref. 17) or via IL-2 and its receptor 18, 19 results in profound T reg cell impairment and autoimmunity. Paradoxically, while T reg cell function requires the constant presence of such activating signals, T reg cells display diminished activity of several key downstream signaling pathways, including the metabolic-checkpoint kinase mTOR pathway 3, 20 and the phosphatidylinositol-3-OH kinase (PI(3)K)-kinase AKT pathway 21, 22 , compared with that of other antigen-experienced T cells. Therefore, T reg cells utilize additional negative regulators that are not active in conventional T cells (T conv cells) to 'rewire' these downstream signaling relays. Published reports have established that negative regulation of the PI(3)K-AKT pathway by the Nrp1-SEMA4a axis 23 and of the mTORC2 pathway by the inositol phosphatase PTEN 22 in T reg cells is indispensable for the maintenance of their suppressive function. However, very little is known about how T reg cells control the mTORC1 complex in a cell-intrinsic manner and whether this regulation is integral for their function.
In this report, we found that the serine-threonine phosphatase PP2A controlled the activity of the mTORC1 complex in T reg cells. This allowed them to maintain a metabolic and cytokine profile essential for their suppressive function. T reg cell-specific loss of PP2A caused a severe lymphoproliferative and autoimmune disorder with spontaneous activation of the immune system and autoantibody production. subunit (PP2A A ) and the regulatory B subunit (PP2A B ) 6, 7 . We compared the catalytic activity of the PP2A complex in T reg cells with that in T conv cells and found that T reg cells displayed greater PP2A activity (Supplementary Fig. 1a ). The nascent catalytic PP2A C subunit, which is generated via one of two isoforms (Cα and Cβ), is produced in an inactive state and undergoes an activation process that is coupled to its incorporation with the scaffold PP2A A subunit into the heterodimeric PP2A A -PP2A C core [24] [25] [26] . The absence of PP2A A prevents maturation of the catalytic subunit into its active state and thus the catalytic activity of PP2A is impaired 24 . The scaffold PP2A A subunit is also generated via one of two isoforms, Aα and Aβ (encoded by Ppp2r1a and Ppp2r1b respectively), with the former being the dominant in primary and secondary lymphoid organs 27 , as well as in isolated CD4 + T cells ( Supplementary  Fig. 1b) . Accordingly, to study the role of PP2A in T reg cell function, we deleted the dominant Aα isoform of the scaffold PP2A A subunit in a T reg cell-specific manner by crossing Foxp3 YFP-cre mice (which express yellow fluorescent protein (YFP) and Cre recombinase via the T reg cell-specific gene Foxp3) with Ppp2r1a flox/flox mice (in which exons 5-6 of Ppp2r1a are loxP flanked) to generate Foxp3 YFP-cre Ppp2r1a flox/flox mice (called 'PP2A flox mice' here) and Foxp3 YFP-cre Ppp2r1a flox/+ or Foxp3 YFP-cre Ppp2r1a +/+ mice (collectively called 'PP2A wt mice' here, because we did not appreciate any haploinsufficiency of Ppp2r1a in the T reg cell population).
By the age of 10-14 weeks, the PP2A flox mice spontaneously developed severe, progressive, multi-organ autoimmunity characterized by wasting, dermatitis, scaly tails and ears, eyelid crusting and, in some cases, overt skin rash and ulcerations ( Fig. 1a and Supplementary  Fig. 1c-f) . The clinical picture displayed similarities to the phenotype of scurfy mice, which harbor a spontaneous mutation mapped to Foxp3 (ref. 28 ) and develop early-onset, multi-organ autoimmunity. Upon macroscopic examination of the organs, it was evident that the PP2A flox mice suffered a lymphoproliferative syndrome with enlargement of the secondary lymphoid organs (Fig. 1b and Supplementary  Fig. 1g,h ). Histological examination of the PP2A flox mice revealed extensive inflammatory infiltrates in the lungs, stomach, pancreas, salivary glands and skin ( Fig. 1c and Supplementary Fig. 1d ). In the lungs, extensive lymphocytic infiltrates were appreciable, especially in the perivascular and peribronchial areas. This cellular infiltration was accompanied by parenchymal consolidation and thickening of the alveolar walls. In the skin, dermal thickening and epidermal hyperplasia with spongiosis, hyperkeratosis and parakeratosis were noted. Lymphoid and polymorphonuclear aggregates in the dermis were abundant and occasionally extended into the epidermis. Focal micro-abscess formation in the stratum corneum and ulceration were also observed. Periductal and perivascular lymphocytic infiltrates were evident in the pancreas and salivary glands and around the pancreatic islets of the PP2A flox mice. In the stomach, inflammatory aggregates, composed of lymphocytes, polymorphonuclear leukocytes and eosinophils, were observed in the submucosa protruding into the adjacent mucosal layer.
The spontaneous autoimmune phenotype of the PP2A flox mice prompted us to assess the status of their immune system compared with that of their PP2A wt littermates. We observed greater activation of both CD4 + T cells and CD8 + T cells in PP2A flox mice relative to that of their PP2A wt littermates, as indicated by the presence of a greater frequency of CD44 + CD62L − CD4 + , CD44 + CD62L − CD8 + and CD44 + CD62L + CD8 + T cells in the spleen and peripheral and mesenteric lymph nodes of PP2A flox mice (Fig. 2a) . When stimulated ex vivo, CD4 + T cells from PP2A flox mice produced significantly larger amounts of IL-17 and IL-2, and CD8 + T cells from PP2A flox mice produced greater amounts of interferon-γ and tumor-necrosis factor (TNF), relative to that of their PP2A wt counterparts (Fig. 2b) . Incorporation of the thymidine analog EdU by CD4 + T cells was greater in PP2A flox mice than in their PP2A wt littermates (Supplementary Fig. 2 ), which demonstrated their enhanced proliferative state. PP2A flox mice had higher concentrations of all immunoglobulin classes (Fig. 2d) . To determine whether PP2A flox mice produced autoantibodies, we used an autoantigen array that assesses 128 known autoantigens. We detected the presence of IgG autoantibodies to 76 autoantigens that included both tissue-restricted autoantigens and lupus-associated nuclear autoantigens (Fig. 2e) Ceramide accumulation activates PP2A in T reg cells Our results suggested that PP2A was necessary for T reg cells to maintain their suppressive function. Thus, we investigated the mechanisms that regulate the activity of the PP2A complex in T reg cells. Whereas the abundance of the catalytic PP2A C subunit is stable in a given cellular state 29 , its activity is controlled through post-translational modifications at its carboxy-terminal tail 30 . Specifically, phosphorylation of the Tyr307 residue at the carboxy-terminal end of PP2A C results in the inactivation of PP2A 30, 31 . When we activated wild type CD4 + T conv cells with antibody to the invariant signaling protein CD3 (anti-CD3) plus anti-CD28, we detected phosphorylation of PP2A C at Tyr307 within 24 h of activation (Fig. 3a) . However, we did not detect the same phosphorylation in T reg cells, which retained small amounts of Tyr307 phosphorylation after stimulation with anti-CD3 plus anti-CD28 ( Fig. 3b and Supplementary Fig. 3a ), consistent with their enhanced PP2A activity ( Supplementary Fig. 1a) . Notably, the 
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A r t i c l e s total amount of the PP2A C subunit in T reg cells was similar to that in T conv cells both before stimulation with anti-CD3 plus anti-CD28 and after such stimulation (Fig. 3c) .
The phosphorylation of PP2A C at Tyr307 is under the control of the ceramide-SET pathway. SET (originally named 'I 2 PP2A' for 'inhibitor 2 of PP2A') has been identified as an inducer of the phosphorylation of PP2A C at Tyr307 and thus as an inhibitor of PP2A activity [32] [33] [34] . We found that in CD4 + T cells, Set was a highly TCR-responsive gene with kinetics of induction that paralleled those of the phosphorylation of PP2A C at Tyr307 following stimulation of CD4 + T cells with anti-CD3 plus anti-CD28 (Fig. 3d) . Lentiviral infection of CD4 + T cells with a Set-expressing vector and knockdown of Set expression via short hairpin RNA promoted the phosphorylation of PP2A C at Tyr307 and decreased such phosphorylation, respectively, after stimulation of the cells with anti-CD3 plus anti-CD28 ( Fig. 3e and Supplementary  Fig. 3b) ; this indicated that SET was responsible for the Tyr307-phosphorylation of PP2A C after activation of CD4 + T cells. However, T reg cells and T conv cells exhibited similar induction of SET upon stimulation with anti-CD3 plus anti-CD28 (Fig. 3f) . Thus, to investigate the cause of differential Tyr307-phosphorylation of PP2A C in T reg cells and T conv cells, we turned our focus to ceramide, the upstream regulator of the ceramide-SET pathway. Specifically, the SET-mediated induction of the phosphorylation of PP2A C at Tyr307 can be abolished by an increase in the intracellular abundance of ceramide, because ceramide interacts with SET and constraints its inhibitory action on the PP2A complex and thus represents an important endogenous PP2A activator [35] [36] [37] . Indeed, treatment of T cells with sphingomyelinase (SMase), which increased the endogenous ceramide content (Fig. 4a) , diminished the association of SET with PP2A C (Supplementary Fig. 3c) . Accordingly, the treatment of activated CD4 + T cells with SMase decreased the Tyr307-phosphorylation of PP2A C (Fig. 4b and Supplementary Fig. 3d) . To quantify the abundance of the ceramide species present in T reg CD4 + cells and T conv CD4 + cells, we used high-performance liquid chromatography coupled with electrospray-ionization tandem mass spectrometry and found that T reg cells had larger amounts of several ceramide species than did T conv cells (Fig. 4c) . Flow cytometry analyzing total ceramide content confirmed those results at the single-cell level (Fig. 4d) .
We subsequently explored the mechanism that led to the T reg cellspecific accumulation of intracellular ceramide. The sphingomyelin SMS1 (encoded by Sgms1) is an enzyme of the sphingolipid-metabolism pathway that has been shown to be part of the T reg cell signature 38 and is underexpressed in T reg cells. SMS1 catalyzes the conversion of ceramide and phosphatidylcholine to diacylglycerol and sphingomyelin. Small amounts of SMS1 result in the intracellular accumulation of ceramide 39, 40 . Chromatin immunoprecipitation (ChIP) experiments demonstrated that Sgms1 was a direct target of Foxp3 (Fig. 4e) , and retroviral overexpression of FOXP3 in Jurkat human T lymphocytes decreased the expression of SGMS1 at the level of mRNA and protein (Supplementary Fig. 4a,b) , in agreement with published data 41 . Accordingly, lentiviral infection of mouse CD4 + T cells with an Sgms1-expressing vector reduced the intracellular abundance of ceramide (Fig. 4f) . Therefore, the T reg cells had a cellintrinsic mechanism for maintaining their increased PP2A activity. Foxp3-mediated suppression of Sgms1 resulted in the accumulation of ceramide in T reg cells that led to activation of the PP2A complex.
PP2A inhibits mTORC1 in T reg cells
To delineate the specific contribution of ceramide-mediated activation of PP2A to T reg cell function, we activated the PP2A complex in Jurkat T cells through the use of SMase. Immunoprecipitation of PP2A C was performed, and bands that represented increased association with PP2A C after treatment with SMase were subjected to mass spectrometry (Supplementary Fig. 5a ). The results were controlled via calculation of the false-discovery rate, and any hits that were identified in bands of the same height in the IgG fraction were excluded from further analysis. We identified 269 distinct proteins associated with PP2A C after activation with ceramide (Supplementary Table 1) . Ingenuity Pathway Analysis (IPA) revealed that components of the mTOR pathway were among the proteins most associated with PP2A C after activation with ceramide (Supplementary Fig. 5b) . We verified the association of PP2A C with Raptor, one of the proteins identified and a key component of the mTORC1 complex, after treatment of cells with SMase (Supplementary Fig. 5c ). To determine the specific effect of the activation of PP2A on the mTOR signaling pathway, we assessed the activity of the mTORC1 complex by checking the phosphorylation of ribosomal S6 protein, assessed the activity of the mTORC2 complex by checking the phosphorylation of AKT at Ser473, and assessed the activity of the PI(3)K-AKT pathway by checking the phosphorylation of AKT at Thr308. The activation with ceramide had a distinct effect on the activity of mTORC1 complex and a negligible effect on mTORC2 and PI(3)K (Fig. 5a) . We obtained similar results when we used isolated primary mouse CD4 + T cells. Specifically, treatment of the CD4 + T cells with SMase significantly diminished the phosphorylation of S6, and pharmacological inhibition of PP2A with okadaic acid increased the phosphorylation of S6 (Fig. 5b) . Notably, the SMase-induced decrease in the phosphorylation of S6 was completely abrogated when PP2A was inhibited with okadaic acid (Fig. 5b) . We observed a slight decrease in the phosphorylation of AKT at Ser473 and no change in its phosphorylation at Thr308 upon treatment of mouse CD4 + T cells with SMase (Fig. 5b) . Flow cytometry analyzing phosphorylated S6 in T reg cells immediately after isolation from PP2A wt and PP2A flox mice (directly ex vivo) showed that PP2A flox T reg cells had significantly more phosphorylation of S6 than did PP2A wt T reg cells (Fig. 5c) . mTOR is centrally involved in the regulation of several key cellular processes, including nutrient sensing, cell proliferation and metabolism 42 . In T cells, mTOR additionally exerts control over cytokine production and T cell differentiation 3 . The increased activity of the mTORC1 complex in PP2A flox T reg cells (Fig. 5c) , coupled with the loss of T reg cell-mediated tolerance in PP2A flox mice (Figs. 1 and 2 and Supplementary Figs. 1 and 2) , prompted us to assess the phenotypic characteristics of PP2A flox and PP2A wt T reg cells. Specifically, we quantified the glycolytic and mitochondrial respiratory capacity of these cells with an extracellular flux analyzer. PP2A flox T reg cells had a significantly higher baseline and maximum glycolytic rate than that of PP2A wt T reg cells (Fig. 6a) . Similarly, PP2A flox T reg cells displayed an increased oxidative-phosphorylation rate both at baseline and at maximum capacity, relative to that of PP2A wt 
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A r t i c l e s T reg cells (Fig. 6b) . The augmented glycolytic and oxidativephosphorylation rates of the PP2A flox T reg cells were comparable to or higher than the corresponding rates in PP2A wt T conv cells before and after stimulation with anti-CD3 plus anti-CD28 ( Supplementary  Fig. 6a) . In vivo determination of the proliferation rate of T reg cells was done by intraperitoneal injection of EdU into PP2A wt and PP2A flox mice. PP2A flox T reg cells displayed increased incorporation of EdU (Fig. 6c) , which indicated that they proliferated more than the PP2A wt T reg cells did. These results were congruent with our observation of a greater frequency of T reg cells in the spleen and peripheral and mesenteric lymph nodes of the PP2A flox mice than in those of PP2A wt mice (Fig. 6d) . In addition, ex vivo stimulation with the phorbol ester PMA and ionomycin resulted in greater production of IL-2 and IL-17 in PP2A flox T reg cells than in PP2A wt T reg cells (Fig. 6e) . PP2A flox T reg cells and PP2A wt T reg cells exhibited similar expression of the surface markers CD25, CTLA-4, PD-1, LAP, CD73, GITR and FR-4 ( Fig. 6f and Supplementary Fig. 6b ), but PP2A flox T reg cells had higher expression of the large neutral amino acid-transporter CD98 (LAT1), which depends on mTORC1 activity 43 , than that of PP2A wt T reg cells (Fig. 6g) . In an in vitro suppression assay, PP2A flox T reg cells did not suppress the proliferation of effector T cells to the same extent that PP2A wt T reg cells did (Fig. 6h) .
To determine the functional importance of the deregulation of the mTORC1 pathway in PP2A-deficient T reg cells, we assessed the ability of the mTORC1 inhibitor rapamycin to reverse the abnormal phenotype of the PP2A flox T reg cells. Treatment of PP2A flox T reg cells npg with rapamycin in vitro diminished the production of IL-2 and IL17 (Fig. 7a) . In addition, rapamycin normalized the increased glycolytic and oxidative-phosphorylation rates of these cells to the rates of the PP2A wt T reg cells (Fig. 7b) . In vivo administration of rapamycin (3 mg per kg body weight, intraperitoneally, every other day 44 ) to PP2A flox mice reduced the infiltration of leukocytes into the affected peripheral tissues (Fig. 7c) . Such in vivo administration of rapamycin also normalized the proportion and number of effector CD4 + T cells and CD8 + T cells in PP2A flox mice such that these were comparable to those of untreated PP2A wt mice (Supplementary Fig. 7a,b) . T reg cells from the rapamycin-treated PP2A flox mice displayed less phosphorylation of S6 than that of T reg cells from untreated PP2A flox mice (Fig. 7d) , indicative of diminished mTOR signaling. This inhibition was also indicated by a reduction in the surface expression of CD98 (Fig. 7e) . Notably, T reg cells from rapamycin-treated PP2A flox mice effectively suppressed the proliferation of PP2A wt naive CD4 + T cells activated in vitro with anti-CD3 plus anti-CD28 (Fig. 7f) . In addition, rapamycin treatment decreased the proportion of follicular helper T cells and germinal center B cells in PP2A flox mice compared with that in untreated PP2A flox mice (Supplementary Fig. 7c,d) , such that these were comparable to those of untreated PP2A wt mice. We concluded that PP2A-mediated inhibition of mTORC1 was necessary for the suppressive function of T reg cells and that the treatment of PP2A flox T reg cells with rapamycin in vitro and in vivo re-established their suppressive function and metabolic and cytokine profile.
DISCUSSION
With the exception of the role of PTEN, the role of intracellular phosphatases in the control of T reg cell function is poorly understood. In this article, we reported that T reg cells required PP2A, an evolutionary conserved serine-threonine phosphatase, to suppress the effector function of cells of the immune system. Mass spectrometry, pathway-enrichment analysis and intracellular signaling analysis revealed that PP2A operated though inhibition of the mTORC1 pathway. Published studies have shown that increased activity of the mTOR pathway negatively affects the generation and function of T reg cells 20, 22, 45, 46 . Interestingly, abrogation of the mTORC1 complex in T reg cells in Foxp3 YFP-cre Rptor flox/flox mice (which undergo deletion of loxP-flanked alleles encoding Raptor via Cre expressed via Foxp3) 43 also disrupts T reg cell function, which indicates that fine regulation of the activity of this pathway, rather than its complete absence, is the determining factor for T reg cell 'operational fitness' . Ceramidemediated activation of PP2A provided T reg cells with the requisite phosphatase activity for control of mTORC1 and established their tolerogenic metabolic and cytokine profile.
Foxp3, the main transcriptional regulator of T reg cells, utilizes the pre-existent transcriptional landscape of the activated CD4 + T cell to establish T reg cell function 47 and acts largely as a repressor 41 . However, understanding of the 'translation' of Foxp3-dependent epigenetic regulation into intracellular signaling events is limited. Ceramides have been recognized as important intracellular bioactive metabolites and second messengers 48 . A major effect of ceramide is activation of the PP2A complex [35] [36] [37] . SMS1, an enzyme of sphingolipid metabolism, regulates the amount of ceramide in a cell and has consistently been recognized in microarray studies as being encoded by one of the main genes repressed in T reg cells 38 . Here we found that Sgms1 was a direct target of Foxp3 and thus we have provided a link between Foxp3 function and PP2A-mediated signaling effects.
PP2A has been linked to the regulation of key intracellular signaling pathways, including but not limited to the AKT, MAPK and JAK-STAT pathways 7, 8 . The relative importance of each of these associations depends on the cellular type and the biological response investigated. Thus, it was crucial in our system to define the main downstream signaling events following the activation of PP2A. Our experiments have highlighted the importance of the interaction between PP2A and the mTOR pathway in T reg cells. Given the well-established association of PP2A with AKT 49 and of AKT with T reg cells [21] [22] [23] 50 , we independently investigated the effect of PP2A activation on AKT phosphorylation. We found that ceramide-mediated activation of PP2A had minimal effect on the mTORC2-dependent phosphorylation of AKT at Ser473 and had no effect on the PI(3)K-mediated phosphorylation of AKT at Thr308. We concluded that the activation of PP2A in T reg cells in a ceramide-dependent manner targeted mainly the mTORC1 signaling.
In this report, we have provided evidence that T reg cell function depends on the presence of PP2A. Moreover, in its absence, mice developed profound lymphoproliferation and autoimmunity. We propose that therapeutic enhancement of PP2A activity in T reg cells should mitigate autoimmunity and transplant rejection and that inhibition of the PP2A complex in T reg cells should compromise their function and promote the fight of the immune system against cancer.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Mice. C57BL/6J (strain: 000664), Foxp3-IRES-eGFP (strain: 018628) and CD45.1 (strain: 002014) mice were purchased from the Jackson Laboratory. To generate PP2A flox , Ppp2r1a flox/flox mice 51 (strain: 017441, Jackson Laboratory, FVB background) were backcrossed for at least seven generations into C57BL/6J mice. Subsequently, they were bred with Foxp3 YFP-cre mice 52 (strain: 016959, Jackson Laboratory) to generate Foxp3 YFP-cre Ppp2r1a flox/flox mice. Both age-and sex-matched male and female mice at the age of 10-14 weeks (unless indicated otherwise in the figure legend) were used for experiments. For the in vivo treatment experiments with rapamycin, 3 mg/kg of rapamycin was administrated by i.p. injection every other day as described previously 44 for 4-5 weeks. Blood was collected before the first administration and weekly afterwards to assess lymphocyte activation. All mice were bred and housed in a specific pathogen-free environment in a barrier facility in accordance to the Beth Israel Deaconess Medical Center Institutional Animal Care and Use Committee (IACUC).
Antibodies and reagents. Anti-PP2A C (1D6; Millipore), antibody to PP2A C phosphorylated at Tyr307 (E155; Epitomics), anti-SET (EPR12972(B); Abcam), anti-Raptor (24C12; Cell Signaling), anti-Foxp3 (150D (BioLegend) and D6O8R (Cell Signaling)), anti-ceramide (MID 15B4; Sigma-Aldrich), Pacific Blue-conjugated antibody to phosphorylated S6 (D57.2.2E; Cell Signaling), Alexa Fluor 647-conjugated antibody to AKT phosphorylated at Ser473 (D9E; Cell Signaling), Alexa Fluor 488-conjugated antibody to AKT phosphorylated at Thr308 (C31E5E; Cell Signaling) and anti-SGMS1 (PA1-12761; Thermo Scientific) were used for immunoblot analysis, immunoprecipitation, ChIP and flow cytometry experiments. Staining for phospho-flow experiments was performed using the Beckman Coulter PerFix Expose kit (B26976). Antibodies for T cell and B cell sorting and analysis of cytokine production by flow cytometry were as follows (all from BioLegend): anti-CD3 (145-2C11), anti-CD4 (GK1.5), anti-CD8 (53-6.7), anti-CD44 (IM7), anti-CD62L (MEL-14), anti-CD45.1 (A20), anti-CXCR5 (2G8), anti-PD1 (29F.1A12), anti-GL7 (114612), anti-FAS (15A7), anti-CD25 (3C7 and PC61), anti-CTLA4 (UC10-4B9), anti-CD73 (TY/11.8), anti-LAP (TW7-16B4), anti-GITR (DTA-1), anti-FR4 (TH6 and 12A5), anti-CD98 (RL388), anti-IL-17 (TC11-18H10.1), anti-IL-2 (JES6-5H4), anti-interferon-γ (XMG1.2), anti-IL-4 (11B11) and anti-TNF (MP6-XT22). All antibodies have been validated by their suppliers and references can be found on their website or on the online validation databases Antibodypedia and 1DegreeBio. Antibody dilutions were 1:1,000 for immunoblot analysis, immunoprecipitation and ChIP experiments and 1:100 for flow cytometry experiments. Sphingomyelinase (SMase; used at 0.5 units/ml) from Staphylococcus aureus (S8633), okadaic acid (O9381; used at 10 nM) and rapamycin (R0395) were from Sigma-Aldrich. Enzyme-linked immunosorbent assays for mouse IgM, IgG, IgE and IgA were from Affymetrix-eBiosciences. For in vivo cell proliferation experiments, the Click-iT Plus EdU Alexa Fluor 647 Flow Cytometry Assay Kit (C10634; Life Technologies) was used per the manufacturer's instructions.
Glycolytic and mitochondrial respiration rate measurement. For metabolic experiments, a Seahorse XF24 instrument was used. Foxp3-eGFP + or Foxp3-YFP + CD4 + T cells sorted by flow cytometry (Fig. 6a,b) and CD4 + CD25 + T cells (isolated as described below; Supplementary Fig. 6a ) were seeded at a density of 5 × 10 5 per well. The extracellular acidification rate (ECAR) and the oxygen consumption rate (OCR) for each well were calculated, while the cells were subjected to the XF Cell Mito or the XF Glycolytic stress test protocols. The XF Cell Mito and the XF Glycolytic stress test kits were purchased from Seahorse Biosciences.
T cell isolation. T reg cell isolation for immunoblot analysis, mass spectrometry and ChIP experiments was performed using the magnetic separation Dynabeads FlowComp Mouse CD4 + CD25 + T reg Cells kit (11463D) from Life Technologies. For all other experiments, T reg cells were sorted on a FACSAria II (Becton, Dickinson) as CD3 + CD4 + CD25 + Foxp3-eGFP + T cells. Naive CD4 + T cell isolation was performed with the magnetic separation Naive CD4 + T Cell Isolation kit (130-104-453) from Miltenyi Biotech. In all instances, cells were sorted to more than 95% purity.
Mass spectrometry. Ceramide species were quantified by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry at the Lipidomics Analytical Core Facility of the Medical University of South Carolina, as previously described 53 . 3 × 10 6 T conv cells and 3 × 10 6 T reg cells were analyzed, after lipid extraction, together with internal sphingolipid controls, on a Thermo Fisher Scientific triple quadrupole mass spectrometer operating in a multiple reaction monitoring (MRM) positive ionization mode for the quantification of ceramide species.
For the identification of PP2A C -interacting proteins, Jurkat T cells were treated with sphingomyelinase (0.5 units/ml) or vehicle (50% glycerol in PBS) for 1 h and then were lysed for protein immunoprecipitation with a PP2A Cspecific antibody (1D6; Millipore) or a mouse IgG control antibody (MG2b-57; Biolegend). Immunoblot analysis was performed under denaturating conditions with the immunoprecipitates separated on two different gels: a 4-12% Bis-Tris gel (SDS-PAGE, pH 7.0; NuPage Novex Life Technologies) with effective range of separation of 2-200 kilodaltons (Supplementary Fig. 5a ) and a 3-8% Tris-Acetate gel (pH 8.1; NuPage Novex Life Technologies) with effective range of separation of 36-400 kilodaltons (data not shown). Bands that were represented differentially by the SMase-and vehicle-treated groups were subjected to mass spectrometry for identification of PP2A C -interacting proteins after ceramide-mediated PP2A activation. The bands with corresponding height at the IgG control lane were also excised and any proteins identified were excluded. The results were controlled for false-discovery rate and the proteins identified were analyzed with Qiagen's Ingenuity Pathway Analysis (IPA) software for the identification of pathway enrichment in the data set.
Autoantigen microarray. Serum from 10-to 14-week-old PP2A wt and PP2A flox mice was analyzed for the presence of autoantibodies using the Autoantigen Microarray Super Panel (128-antigen panel) at the Genomics and Microarray Core facility of the University of Texas Southwestern Medical Center. Autoantibodies with a statistically significant difference between the two groups were used to create a row-normalized heat-map analysis with R software.
Code availability. The pathway analysis for the mass spectrometry data in Supplementary Figure 5b was done with the use of QIAGEN's Ingenuity Pathway Analysis (QIAGEN: http://www.qiagen.com/ingenuity; IPA Winter Release 2014).
R software was used to analyze and generate the results of the autoantigen array 54 (Fig. 2e). PP2A C enzymatic activity. PP2A C enzymatic activity was assessed using the PP2A Immunoprecipitation Phosphatase Assay Kit (17-313; Millipore) per the manufacturer's instructions. Protein extracts were immunoprecipitated with a PP2A C -specific antibody (1D6; Millipore). An appropriate phosphorylated peptide (amino acid sequence K-R-pT-I-R-R, where 'pT' indicates phosphorylated threonine) was added to the immunoprecipitated immunocomplexes as a substrate for PP2A C , and samples were incubated at 30 °C in a shaking incubator for 10 min. Supernatants (25 µl) were transferred to a 96-well plate and released phosphate was measured by the addition of 100 µl malachite green phosphate detection solution in a 15-min colorimetric reaction. Phosphate concentrations were calculated from a standard curve created using serial dilutions of a standard phosphate solution.
In vitro suppression assay. CD45.1 + CD4 + CD62L + CD25 − CD44 − T cells (1 × 10 5 ; T eff cells) were stained with CFSE (carboxyfluorescein diacetate succinimidyl ester; Life Technologies) and were cultured for 4 d with PP2A wt or PP2A flox T reg cells in serially decreasing ratios (1:1, 1:2, 1:4, 1:8, only T eff cells) in the presence of 1 × 10 5 irradiated splenocytes and plate-bound anti-CD3 (2 µg/ml; 145-2C11; BioXcell). T eff cell proliferation was assessed by flow cytometry as the dilution of CFSE at the end of the 4-day culture.
Plasmid, retroviral and lentiviral infection. For SET-silencing experiments, the psi-mU6 mCherry-expressing vector was used, which harbors SETspecific or scrambled control short hairpin RNA (Genecopeia). For lentiviral overexpression of SMS1 and SET, the full coding sequences of mouse Sgms1
